2025-524168-39-00招募中1 期
A clinical study to test MEN2501 in patients with treatment-resistant ovarian cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 23
- 试验地点
- 12
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development and Clinical Operations
Scientific
Stemline Therapeutics Inc.
研究点 (12)
Loading locations...
相似试验
已完成
1 期
A Phase 1b Study of AMG 757 in Subjects with Neuroendocrine Prostate Cancer2024-513316-10-00Amgen Inc.11
已完成
1 期
A trial to learn if different doses of REGN17092 are safe in healthy adults2023-505041-52-00Regeneron Pharmaceuticals Inc.128
已完成
1 期
This is clinical study to test, for the first time in people, the safety (any
good or bad effects), how long the drug can stay in the body and if it can
control the disease of people diagnosed with advanced cancer that has not
responded to treatment, has returned after it has been treated, or cannot
be treated by surgery, drugs, or any other known treatments.2023-509969-20-00Celgene Corp.127
已完成
1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113